Home - Products - Others - Other Targets - Tetrahydrofurfuryl propionate

Tetrahydrofurfuryl propionate

CAS No. 637-65-0

Tetrahydrofurfuryl propionate( AI3-15415 | AI3 15415 | AI315415 )

Catalog No. M27270 CAS No. 637-65-0

Tetrahydrofurfuryl propionate is a carboxylate fragrance.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 63 In Stock
25MG 103 In Stock
50MG 150 In Stock
100MG 223 In Stock
500MG 482 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tetrahydrofurfuryl propionate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tetrahydrofurfuryl propionate is a carboxylate fragrance.
  • Description
    Tetrahydrofurfuryl propionate is a carboxylate fragrance.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AI3-15415 | AI3 15415 | AI315415
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    c-Met
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    637-65-0
  • Formula Weight
    173.189
  • Molecular Formula
    C8H13O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCC1(CCC([O-])=O)CCCO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jonathan S Bromberg, et al. Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation. Transplantation. 2021 Feb 1;105(2):443-450.
molnova catalog
related products
  • β-Casomorphin, bovin...

    β-Casomorphin, bovine TFA (β-Casomorphin-7 (bovine) TFA) is a opioid peptide with an IC50 of 14 μM in an Opioid receptors binding assay.

  • Vonlerolizumab

    Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.

  • Temozolomide Acid

    Temozolomide Acid is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.